JP2010523644A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523644A5
JP2010523644A5 JP2010502609A JP2010502609A JP2010523644A5 JP 2010523644 A5 JP2010523644 A5 JP 2010523644A5 JP 2010502609 A JP2010502609 A JP 2010502609A JP 2010502609 A JP2010502609 A JP 2010502609A JP 2010523644 A5 JP2010523644 A5 JP 2010523644A5
Authority
JP
Japan
Prior art keywords
amino
dione
trifluoromethyl
methyl
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010502609A
Other languages
English (en)
Japanese (ja)
Other versions
JP5635396B2 (ja
JP2010523644A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2008/003036 external-priority patent/WO2009031040A2/en
Publication of JP2010523644A publication Critical patent/JP2010523644A/ja
Publication of JP2010523644A5 publication Critical patent/JP2010523644A5/ja
Application granted granted Critical
Publication of JP5635396B2 publication Critical patent/JP5635396B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010502609A 2007-04-11 2008-04-11 抗がん活性を有する化合物 Active JP5635396B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91125807P 2007-04-11 2007-04-11
US60/911,258 2007-04-11
PCT/IB2008/003036 WO2009031040A2 (en) 2007-04-11 2008-04-11 Compounds with anti-cancer activity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013176324A Division JP2014012706A (ja) 2007-04-11 2013-08-28 抗がん活性を有する化合物

Publications (3)

Publication Number Publication Date
JP2010523644A JP2010523644A (ja) 2010-07-15
JP2010523644A5 true JP2010523644A5 (enExample) 2011-05-12
JP5635396B2 JP5635396B2 (ja) 2014-12-03

Family

ID=39939984

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010502609A Active JP5635396B2 (ja) 2007-04-11 2008-04-11 抗がん活性を有する化合物
JP2013176324A Withdrawn JP2014012706A (ja) 2007-04-11 2013-08-28 抗がん活性を有する化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013176324A Withdrawn JP2014012706A (ja) 2007-04-11 2013-08-28 抗がん活性を有する化合物

Country Status (17)

Country Link
US (2) US8084454B2 (enExample)
EP (4) EP4074704A1 (enExample)
JP (2) JP5635396B2 (enExample)
KR (1) KR101475311B1 (enExample)
CN (2) CN101720323A (enExample)
AU (1) AU2008294410B2 (enExample)
BR (2) BR122022005149B1 (enExample)
CA (4) CA3030510C (enExample)
DK (2) DK3567035T3 (enExample)
ES (3) ES2732230T3 (enExample)
HU (2) HUE029370T2 (enExample)
IL (4) IL309201A (enExample)
MX (3) MX374896B (enExample)
NZ (1) NZ580237A (enExample)
RU (1) RU2482111C2 (enExample)
WO (1) WO2009031040A2 (enExample)
ZA (1) ZA200906960B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3567035T3 (da) * 2007-04-11 2022-09-05 Canbas Co Ltd N-substituerede 2,5-dioxo-azolin-forbindelser til anvendelse ved behandling af cancer
EP2304436A1 (en) 2008-07-10 2011-04-06 Nodality, Inc. Methods for diagnosis, prognosis and treatment
EP3620154A1 (en) * 2009-02-06 2020-03-11 University Of Southern California Therapeutic compositions comprising monoterpenes
US20100215644A1 (en) * 2009-02-25 2010-08-26 Nodality, Inc. A Delaware Corporation Analysis of nodes in cellular pathways
CN104744215B (zh) 2010-03-03 2019-03-15 尼昂克技术公司 包含单萜的药物组合物
US9499461B2 (en) 2010-08-27 2016-11-22 Neonc Technologies, Inc. Pharmaceutical compositions comprising POH derivatives
US20160038600A1 (en) 2012-08-03 2016-02-11 Neonc Technologies Inc. Pharmaceutical compositions comprising poh derivatives
ES3056006T3 (en) 2010-12-17 2026-02-17 Univ Southern California Methods and devices for using isoperillyl alcohol
WO2013020024A2 (en) * 2011-08-03 2013-02-07 Karyopharm Therapeutics, Inc. Maleimide compounds and methods of treatment
US9814693B2 (en) 2012-05-09 2017-11-14 Delmar Pharmaceuticals, Inc. Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies
ES2563861T3 (es) 2012-06-14 2016-03-16 Daiichi Sankyo Company, Limited Derivado de piperidinilpirazolopiridina
EP2951174B1 (en) * 2013-01-30 2017-04-26 Bayer Pharma Aktiengesellschaft Amino-substituted isothiazoles
US9540462B2 (en) 2014-12-05 2017-01-10 Massachusetts Institute Of Technology Catechol-rich polymers from N-substituted maleimides
SI3250550T1 (sl) * 2015-01-26 2023-08-31 Ottawa Hospital Research Institute Sestave in metode za senzibilizacijo virusov
WO2016130800A2 (en) 2015-02-12 2016-08-18 Neonc Technologies Inc. Pharmaceutical compositions comprising perillyl alcohol derivatives
TW201808906A (zh) 2016-03-16 2018-03-16 拜耳作物科學股份有限公司 作為殺蟲劑之經取代吡啶化合物
USD915100S1 (en) 2016-03-31 2021-04-06 Ocean 22, Llc Spooled item holding device
USD801721S1 (en) 2016-03-31 2017-11-07 Patricia Grayson Briden Spooled item holding device
TW201811766A (zh) 2016-08-29 2018-04-01 瑞士商諾華公司 N-(吡啶-2-基)吡啶-磺醯胺衍生物及其用於疾病治療之用途
JP2021512165A (ja) 2018-01-29 2021-05-13 コグノス・セラピューティクス・インコーポレイテッド ボルテゾミブの腫瘍内送達
MX2020008053A (es) 2018-02-02 2020-09-07 Boehringer Ingelheim Int Derivados de oxadiazolopiridina sustituidos con bencilo, (piridin-3-il)metilo o (piridin-4-il)metilo como inhibidores de ghrelin o-aciltransferasa (goat).
CA3087925A1 (en) 2018-02-02 2019-08-08 Boehringer Ingelheim International Gmbh Triazolopyrimidine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors
JP7325425B2 (ja) 2018-02-08 2023-08-14 ネオンク テクノロジーズ インク. 血液脳関門を透過性にする方法
EP4153599B1 (en) 2020-05-22 2024-03-13 Boehringer Ingelheim International GmbH Process for manufacturing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine-carboxylate
WO2021233884A1 (en) 2020-05-22 2021-11-25 Boehringer Ingelheim International Gmbh Continuous process for manufacturing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine-carboxylate
EP4415700A4 (en) * 2021-10-15 2025-12-24 Univ Missouri P1B TYPE ATPASES INHIBITORS
CN114425054A (zh) * 2022-01-20 2022-05-03 中国人民解放军军事科学院军事医学研究院 一种蛋白酶体抑制剂Bortezomib在抗辐射损伤中的用途
CN120247782B (zh) * 2025-06-04 2025-08-19 北京颖泰嘉和生物科技股份有限公司 氟吡菌酰胺类化合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5564557A (en) * 1978-11-08 1980-05-15 Mitsui Toatsu Chem Inc Diphenyl ether compound and herbicide containing the same
IL81307A0 (en) * 1986-01-23 1987-08-31 Union Carbide Agricult Method for reducing moisture loss from plants and increasing crop yield utilizing nitrogen containing heterocyclic compounds and some novel polysubstituted pyridine derivatives
US5635966A (en) * 1994-01-11 1997-06-03 Hewlett-Packard Company Edge feed ink delivery thermal inkjet printhead structure and method of fabrication
JPH07224032A (ja) 1994-02-09 1995-08-22 Mitsui Petrochem Ind Ltd N−アリールオキシフタルイミド誘導体、その製造方 法及びそれを有効成分として含有する除草剤
JPH07244032A (ja) * 1994-03-01 1995-09-19 Ishikawajima Harima Heavy Ind Co Ltd 溶接部検査装置
AU726058B2 (en) * 1995-09-01 2000-10-26 Signal Pharmaceuticals, Inc. Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions
US5935966A (en) * 1995-09-01 1999-08-10 Signal Pharmaceuticals, Inc. Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions
CA2245029A1 (en) 1998-03-13 1999-09-13 University Of British Columbia Granulatimide compounds as g2 checkpoint inhibitors
US6205557B1 (en) 1998-06-09 2001-03-20 At&T Corp. Redundant call processing
AU2093400A (en) * 1998-11-24 2000-06-13 Basf Aktiengesellschaft Fungicides containing pyrrolidones as their active agents
DE60019318T2 (de) 1999-09-22 2006-03-09 Canbas Co., Ltd., Numazu Zusammensetzungen und verfahren zur inhibierung vom zellulären g2-übergang und sensitisierung von zellen gegen dna-schädigenden wirkstoffe
DE50104105D1 (de) * 2000-02-26 2004-11-18 Basf Ag Fungizide mittel enthaltend als wirkstoffe pyrrolidone und deren verwendung bei der behandlung von pflanzen
JP2002318434A (ja) * 2001-04-23 2002-10-31 Konica Corp ハロゲン化銀写真感光材料、処理方法、および画像形成方法
FR2826653B1 (fr) * 2001-06-29 2005-10-14 Servier Lab Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2487388C (en) 2002-06-06 2011-05-10 Canbas Co., Ltd. Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments
WO2005024755A2 (en) * 2002-12-31 2005-03-17 Deciphera Pharmaceuticals, Llc. Medicaments for the treatment of neurodegenerative disorders or diabetes
US7572816B2 (en) * 2003-08-01 2009-08-11 Auspex Pharmaceuticals, Inc. Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
KR101149124B1 (ko) * 2004-03-10 2012-05-25 가부시끼가이샤 구레하 아민계 염기성 화합물과 그의 용도
CA2559866A1 (en) * 2004-03-31 2005-10-20 Exelixis, Inc. Anaplastic lymphoma kinase modulators and methods of use
EP1851203A2 (en) 2005-02-08 2007-11-07 Merck & Co., Inc. Inhibitors of checkpoint kinases
CA2619706A1 (en) * 2005-08-17 2007-02-22 Schering Corporation Novel high affinity quinoline-based kinase ligands
CN101321747A (zh) * 2005-11-01 2008-12-10 詹森药业有限公司 作为葡萄糖激酶变构调节剂的取代的环烷基吡咯酮类
US7994205B2 (en) * 2006-03-31 2011-08-09 Takeda Pharmaceutical Company Limited Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors
US20080221103A1 (en) 2007-03-09 2008-09-11 Orchid Research Laboratories Ltd. New heterocyclic compounds
DK3567035T3 (da) 2007-04-11 2022-09-05 Canbas Co Ltd N-substituerede 2,5-dioxo-azolin-forbindelser til anvendelse ved behandling af cancer

Similar Documents

Publication Publication Date Title
RU2482111C2 (ru) Соединения, обладающие противораковой активностью
RU2451675C2 (ru) ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА В КАЧЕСТВЕ АГОНИСТОВ β2-АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
CN1942186B (zh) 吡咯烷化合物
JP2013515038A5 (enExample)
JP2013517283A5 (enExample)
JP2009524589A5 (ja) 置換されたイソキノリン−1,3(2h,4h)−ジオン、1−チオキソ−1,4−ジヒドロ−2h−イソキノリン−3−オン、および1,4−ジヒドロ−3(2h)−イソキノロン、ならびにキナーゼインヒビターとしてのそれらの使用
JP2011520941A5 (enExample)
JP2013503901A5 (enExample)
HRP20110939T1 (hr) Supstituirani benzimidazoli kao inhibitori kinaze
JP2012520867A5 (enExample)
KR20010006487A (ko) 조합된 5ht1a, 5ht1b 및 5ht1d 수용체 길항 활성을 갖는 인돌 유도체
JP2025160175A5 (enExample)
RU2017139727A (ru) Гетероциклические ингибиторы erk1 и erk2 и их применение для лечения злокачественного новообразования
JP2009541461A5 (enExample)
JP2005538955A5 (enExample)
JP2016506964A5 (ja) ナトリウムチャネルの調節剤としてのキノリンおよびキノキサリンアミド
JP2015500212A5 (enExample)
JP2008532925A5 (enExample)
RU2010110640A (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
JP2010513304A5 (enExample)
JP2015523383A5 (enExample)
WO2006076575B1 (en) Substituted biaryl compounds as factor xia inhibitors
JP2007536224A5 (enExample)
JP2007522235A5 (enExample)
JP2012520238A5 (enExample)